Accelerate your next cell therapy breakthrough
Cell therapies represent a major breakthrough in the ability to leverage the body’s own immune system to treat disease. Innovators in fields such as Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, and Natural Killer (NK) Cell Therapy are making this potential a reality.
Modern cell therapy R&D requires a strong digital foundation to design novel constructs, perform complex product characterizations, and track production processes from start to finish. Full traceability must be maintained across sequences, cell lines, patient donors, and engineering processes so that critical insights can be derived throughout the R&D process.
Cell Therapy R&D Solution
Benchling’s cell therapy R&D solution is trusted by hundreds of cell therapy innovators to accelerate their R&D. It empowers scientists to discover novel cell therapies with modern tools designed to provide complete, end-to-end traceability of samples, increase throughput and efficiency, and streamline cross-team collaboration. Our modern, digital R&D solution combines all the capabilities expected from the latest in silico design tools, ELN, and LIMS into one intuitive package designed for cell therapy R&D.
See Benchling's Cell Therapy R&D Solution in action
Our Customer Experience professionals possess deep scientific expertise, as well as training on information technology best practices. They apply this know-how to support cell therapy customers across a wide range of R&D teams.
Leverage Benchling's pre-implementation solutions consulting, professional implementation services, and customer success management expertise to help you get the most out of Benchling.
Take advantage of Benchling’s foundational implementation guides, developed by our Customer Experience team to support many cell therapy R&D functions.